Bivariate and multivariate analyses of the correlations between stability of the erythrocyte membrane, serum lipids and hematological variables

Biorheology

Volumn 50, Issue 5-6, 2013, Pages 305-320

  Bernardino Neto, M ^a   De Avelar, E B ^a   Arantes, T S ^a   Jordao I A ^a   Da Costa Huss, J C ^a   De Souza, T M T ^a   De Souza Penha, V A ^a   Da Silva, S C ^a   De Souza, P C A ^a   Tavares, M ^a   Penha Silva, N ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Erythrocyte; hemogram; hypotonic lysis; lipidemia; membrane stability

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BIVARIATE ANALYSIS; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HEMATOLOGICAL PARAMETERS; HUMAN; LIPID BLOOD LEVEL; MIDDLE AGED; MULTIVARIATE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ERYTHROCYTE; HEMOGRAM; HYPOTONIC LYSIS; LIPIDEMIA; MEMBRANE STABILITY;

ERYTHROCYTE MEMBRANE; HEMATOLOGY; HUMANS; LIPIDS; MEMBRANE FLUIDITY; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 84892738381     PISSN: 0006355X     EISSN: 18785034     Source Type: Journal    
DOI: 10.3233/BIR-130641     Document Type: Article

References (62)

1. I. Aloulou, E. Varlet-Marie, J. Mercier and J.F. Brun, Hemorheological disturbances correlate with the lipid profile but not with the NCEP-ATPIII score of the metabolic syndrome, Clin. Hemorheol. Microcirc. 35 (2006), 207-212.
2. E. Arbustini, Total erythrocyte membrane cholesterol-An innocent new marker or an active player in acute coronary syndromes?, J. Am. Coll. Cardiol. 49 (2007), 2090-2092.
3. C.B. Blum, Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, Am. J. Cardiol. 73 (1994), 3D-11D.
4. R. Cazzola, M. Rondanelli, R. Trotti and B. Cestaro, Effects of weight loss on erythrocyte membrane composition and fluidity in overweight and moderately obese women, J. Nutr. Biochem. 22 (2011), 388-392.
5. A. Chabanel, M. Flamm, K.L.P. Sung, M.M. Lee, D. Schachter and S. Chien, Influence of cholesterol content on red-cell membrane viscoelasticity and fluidity, Biophys. J. 44 (1983), 171-176.
6. R.A. Cooper, Anemia with spur cells-a red cell defect acquired in serum and modified in circulation, J. Clin. Invest. 48 (1969), 1820-1831.
7. R.A. Cooper, Abnormalities of cell-membrane fluidity in the pathogenesis of disease, N. Engl. J. Med. 297 (1977), 371-377.
8. R.A. Cooper, E.C. Arner, J.S.Wiley and S.J. Shattil, Modification of red cell membrane structure by cholesterol-rich lipid dispersions. A model for the primary spur cell defect, J. Clin. Invest. 55 (1975), 115-126.
9. R.A. Cooper, J.R. Durocher and M.H. Leslie, Decreased fluidity of red-cell membrane lipids in abetalipoproteinemia, J. Clin. Invest. 60 (1977), 115-121.
10. A. Corsini, S. Bellosta, R. Baetta, R. Fumagalli, R. Paoletti and F. Bernini, New insights into the pharmacodynamic and pharmacokinetic properties of statins, Pharmacol. Therapeut. 84 (1999), 413-428.
11. S. Cribier, G. Morrot and A. Zachowski, Dynamics of the membrane lipid phase, Prostag. Leukotr. Ess. 48 (1993), 27-32.
12. C.C. Cunha, L.R. Arvelos, J.O. Costa and N. Penha-Silva, Effects of glycerol on the thermal dependence of the stability of human erythrocytes, J. Bioenerg. Biomembr. 39 (2007), 341-347.
13. L.R. de Arvelos, V.C. Rocha, G.P. Felix, C.C. da Cunha, M. Bernardino Neto, M. da Silva Garrote Filho et al., Bivariate and multivariate analyses of the influence of blood variables of patients submitted to Roux-en-Y gastric bypass on the stability of erythrocyte membrane against the chaotropic action of ethanol, J. Membr. Biol. 246 (2013), 231-242.
14. M.V. de Freitas, M.R. de Oliveira, D.F. dos Santos, R.D. Mascarenhas, S.B. Fenelon and N. Penha-Silva, Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis, J. Membr. Biol. 233 (2010), 127-134.
15. M.V. de Freitas, R.D.M. Netto, J.C.D. Huss, T.M.T. de Souza, J.O. Costa, C.B. Firmino and N. Penha-Silva, Influence of aqueous crude extracts of medicinal plants on the osmotic stability of human erythrocytes, Toxicol. Vitro 22 (2008), 219-224.
16. D.R. Dewey and K.H. Lu, A correlation and path-coefficient analysis of components of crested wheatgrass seed production, Agron. J. 51 (1959), 515-518.
17. J.F.S. Dwight, A.C.M. Ribeiro and B.M. Hendry, Effects of HMG-CoA reductase inhibition on erythrocyte membrane cholesterol and acyl chain composition, Clin. Chim. Acta 256 (1996), 53-63.
18. L.C. Fonseca, L.R. Arvelos, R.C.M. Netto, A.B. Lins, M.S. Garrote and N. Penha-Silva, Influence of the albumin concentration and temperature on the lysis of human erythrocytes by sodium dodecyl sulfate, J. Bioenerg. Biomembr. 42 (2010), 413-418.
19. G.G. Garzetti, A.L. Tranquilli, A.M. Cugini, L.Mazzanti, N. Cester and C. Romanini, Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia, Obstet. Gynecol. 81 (1993), 337-340.
20. J.F. Hair, W.C. Black, B.J. Babin, R.E. Anderson and R.L. Tatham, Multivariate Data Analysis, Bookman, Porto Alegre, RS, 2009.
21. D.M. Hoefner, S.D. Hodel, J.F. O'Brien, E.L. Branum, D. Sun, I. Meissner and J.P. McConnell, Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System, Clin. Chem. 47 (2001), 266-274.
22. W.L. Hubbell and H.M. McConnell, Molecular motion in spin-labeled phospholipids and membranes, J. Am. Chem. Soc. 93 (1971), 314-326.
23. F.D. Kolodgie, H.K. Gold, A.P. Burke, D.R. Fowler, H.S. Kruth, D.K. Weber et al., Intraplaque hemorrhage and progression of coronary atheroma, N. Engl. J. Med. 349 (2003), 2316-2325.
24. M. Koter, M. Broncel, J. Chojnowska-Jezierska, K. Klikczynska and I. Franiak, The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia, Eur. J. Clin. Pharmacol. 58 (2002), 501-506.
25. J. Lemmich, K.Mortensen, J.H. Ipsen, T. Honger, R. Bauer and O.G. Mouritsen, The effect of cholesterol in small amounts on lipid-bilayer softness in the region of the main phase transition, Eur. Biophys. J. 25 (1997), 293-304.
26. G.S.D. Lemos, L.F. Marquez-Bernardes, L.R. Arvelos, L.F. Paraiso and N. Penha-Silva, Influence of glucose concentration on the membrane stability of human erythrocytes, Cell. Biochem. Biophys. 61 (2011), 531-537.
27. E.L. Lim, K.G. Hollingsworth, B.S. Aribisala, M.J. Chen, J.C. Mathers and R. Taylor, Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol, Diabetologia 54 (2011), 2506-2514.
28. N. Maeda, I. Cicha, N. Tateishi and Y. Suzuki, Triglyceride in plasma: prospective effects on microcirculatory functions, Clin. Hemorheol. Microcirc. 34 (2006), 341-346.
29. N. Malandrino, W.C. Wu, T.H. Taveira, H.B. Whitlatch and R.J. Smith, Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes, Diabetologia 55 (2012), 226-235.
30. M. Martinez, A. Vaya, L. Gil, R. Marti, J. Dalmau and J. Aznar, The cholesterol/phospholipid ratio of the erythrocyte membrane in children with familial hypercholesterolemia. Its relationship with plasma lipids and red blood cell aggregability, Clin. Hemorheol. Microcirc. 18 (1998), 259-263.
31. M. Martinez, A. Vaya, R. Marti, L. Gil, I. Lluch, R. Carmena and J. Aznar, Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin, Thromb Res. 83 (1996), 375-388.
32. K. Michalska-Malecka, L. Slowinska, M. Dorecka and W. Romaniuk, Correlations in some pathogenetic factors and values of hemorheological parameters in age-related mascular degeneration, Clin. Hemorheol. Microcirc. 38 (2008), 209-216.
33. D.P. Montardo, M. Dall'Agnol, A.F. Crusius and N.R. Paim, Path analysis for seed production in red clover (Trifolium pratense L.), Braz. J. Anim. Sci. 32 (2003), 1076-1082.
34. A. Nassief and J.D. Marsh, Statin therapy for stroke prevention, Stroke 39 (2008), 1042-1048.
35. H.E. Niles, Correlation, causation and Wright's theory of "Path Coefficients", Genetics 7 (1922), 258-273.
36. Y. Nishizaki, S. Yamagami, H. Suzuki, Y. Joki, S. Takahashi, M. Sesoko et al., Red blood cell distribution width as an effective tool for detecting fatal heart failure in super-elderly patients, Internal Med. 51 (2012), 2271-2276.
37. M. Okada, T. Matsuto, T. Miida, K. Obayashi, Y. Zhu and Y. Fueki, Lipid analyses for the management of vascular diseases, J. Atheroscler. Thromb. 11 (2004), 190-199.
38. K.V. Patel, J.G. Mohanty, B. Kanapuru, C. Hesdorffer, W.B. Ershler and J.M. Rifkind, Association of the red cell distribution width with red blood cell deformability, Adv. Exp. Med. Biol. 765 (2013), 211-216.
39. N. Penha-Silva, L.R. Arvelos, C.C. Cunha, T.A. Aversi-Ferreira, L.F. Gouvea-e-Silva, M.S. Garrote et al., Effects of glycerol and sorbitol on the thermal dependence of the lysis of human erythrocytes by ethanol, Bioelectrochem. 73 (2008), 23-29.
40. N. Penha-Silva, C.B. Firmino, F.G.D. Reis, J.C.D. Huss, T.M.T. de Souza, M.V. de Freitas and R.D.M. Netto, Influence of age on the stability of human erythrocyte membranes, Mech. Ageing. Dev. 128 (2007), 444-449.
41. R.A. Rabini, M. Polenta, R. Staffolani, M. Tocchini, R. Signore, I. Testa and L. Mazzanti, Effect of hydroxymethylglutaryl-Coa reductase inhibitors on the functional-properties of erythrocyte-membranes, Exp. Mol. Pathol. 59 (1993), 51-57.
42. S. Raffy and J. Teissie, Control of lipid membrane stability by cholesterol content, Biophys. J. 76 (1999), 2072-2080.
43. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole et al., The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, N. Engl. J. Med. 335 (1996), 1001-1009.
44. B.P. Schick and P.K. Schick, Cholesterol exchange in platelets, erythrocytes and megakaryocytes, Biochim. Biophys. Acta 833 (1985), 281-290.
45. E. Sehayek, E. Butbul, R. Avner, H. Levkovitz and S. Eisenberg, Enhanced cellular-metabolism of very-low-density lipoprotein by simvastatin-a novel mechanism of action of HMG-CoA reductase inhibitors, Euro. J. Clin. Invest. 24 (1994), 173-178.
46. K. Seki, H. Sumino, M. Nara, N. Ishiyama, M. Nishino and M. Murakami, Relationships between blood rheology and age, body mass index, blood cell count, fibrinogen and lipids in healthy subjects, Clin. Hemorheol. Microcirc. 34 (2006), 401-410.
47. A. Sena, R. Pedrosa and M.G. Morais, Therapeutic potential of lovastatin in multiple sclerosis, J. Neurol. 250 (2003), 754-755.
48. M. Shinitzky and M. Inbar, Microviscosity parameters and protein mobility in biological-membranes, Biochim. Biophys. Acta 433 (1976), 133-149.
49. M. Sinensky, Homeoviscous adaptation-a homeostatic process that regulates the viscosity of membrane lipids in Escherichia coli, Proc. Natl. Acad. Sci. USA 71 (1974), 522-525.
50. M.I. Spengler, S.M. Bertoluzzo, G. Catalani and M.L. Rasia, Study on membrane fluidity and erythrocyte aggregation in equine, bovine and human species, Clin. Hemorheol. Microcirc. 38 (2008), 171-176.
51. A. Tonkin, P. Aylward, D. Colquhoun, P. Glasziou, P. Harris, S. MacMahon et al., Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels, N. Engl. J. Med. 339 (1998), 1349-1357.
52. D. Tziakas, G. Chalikias, A. Grapsa, T. Gioka, I. Tentes and S. Konstantinides, Red blood cell distribution width-a strong prognostic marker in cardiovascular disease-is associated with cholesterol content of erythrocyte membrane, Clin. Hemorheol. Microcirc. 51 (2012), 243-254.
53. D.N. Tziakas, G.K. Chalikias, D. Stakos, I.K. Tentes, S.V. Chatzikyriakou, K. Mitrousi et al., Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease, Coronary Artery Dis. 19 (2008), 583-590.
54. D.N. Tziakas, G.K. Chalikias, D. Stakos, I.K. Tentes, D. Papazoglou, A. Thomaidi et al., Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation, Int. J. Cardiol. 150 (2011), 22-27.
55. D.N. Tziakas, J.C. Kaski, G.K. Chalikias, C. Romero, S. Fredericks, L.K. Tentes et al., Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome-A new marker of clinical instability?, J. Am. Coll. Cardiol. 49 (2007), 2081-2089.
56. A. Vaya, M. Martinez, R. Carmena and J. Aznar, The lipid-composition of red-blood-cells and their hemorheological behavior in patients with primary hyperlipoproteinemia, Clin. Hemorheol. 13 (1993), 447-457.
57. I. Velcheva, N. Antonova, V. Dimitrova, N. Dimitrov and I. Ivanov, Plasma lipids and blood viscosity in patients with cerebrovascular disease, Clin. Hemorheol. Microcirc. 35 (2006), 155-157.
58. C.Waternaux, Mathematical tools for applied multivariate-analysis-Green, Pe, Carroll, Jd, J. Am. Stat. Assoc. 74 (1979), 244-245.
59. J.S. Wiley and R.A. Cooper, Inhibition of cation cotransport by cholesterol enrichment of human red cell membranes, Biochim. Biophys. Acta 413 (1975), 425-431.
60. S. Wright, The theory of path coefficients: a reply to Niles's criticism, Genetics 8 (1923), 239-255.
61. M.M. Yu, Y. Xu, J.H. Zhang, C.H. Wang, X.C. Wang, Z.P. Cheng and B.L. Xu, Total cholesterol content of erythrocyte membranes levels are associated with the presence of acute coronary syndrome and high sensitivity C-reactive protein, Int. J. Cardiol. 145 (2010), 57-58.
62. D. Zilberman-Kravits, I. Harman-Boehm, T. Shuster and N. Meyerstein, Increased red cell aggregation is correlated with HbA(1C) and lipid levels in type 1 but not type 2 diabetes, Clin. Hemorheol. Microcirc. 35 (2006), 463-471.